跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,776 条关于
“postmenopausal osteoporosis”
全部
3,776
临床试验
3,420
药物
50
机构
5
资讯
301
12个月前
CuraTeQ Biologics Completes Successful Phase 3 Trial for Denosumab Biosimilar in Postmenopausal Osteoporosis
2年前
NICE Approves Eladynos for Postmenopausal Osteoporosis, But NHS Diagnostic Gaps Pose Access Challenges
去年
Equivalence Confirmed: CT-P41 Paves the Way for Affordable Osteoporosis Care
2年前
EMA Validates Marketing Applications for HLX14 Denosumab Biosimilar in Osteoporosis Treatment
去年
Teva's Denosumab Biosimilar Candidate, TVB-009P, Accepted for Review by FDA and EMA
去年
Angitia Biopharmaceuticals Doses First Patient in Phase 2 Trial of AGA2118 for Osteoporosis
去年
Angitia Biopharmaceuticals Doses First Patient in Phase 2 Trial of AGA2118 for Osteoporosis
去年
Entera Bio to Present Phase 2 Osteoporosis Data and Next-Generation Oral Peptide Programs at September 2025 Conferences
去年
FDA Accepts Bone Mineral Density as Primary Endpoint for Entera Bio's Oral Osteoporosis Drug Phase 3 Trial
10个月前
Ingenus Pharmaceuticals Launches First Generic Version of Premarin Tablets After FDA Approval
第 1 页，共 31 页
上一页
下一页
